SUMMARY BACKGROUND: During sepsis, von Willebrand factor (VWF) is abundantly secreted; the main mechanism regulating its size involves specific proteolysis by the metalloprotease ADAMTS-13. OBJECTIVES: To determine whether ADAMTS-13 consumption due to its binding to, and/or cleavage, of VWF contributes to its decrease during sepsis and whether abrogating or enhancing ADAMTS-13 activity influences sepsis outcome. METHODS: ADAMTS-13 activity was evaluated in a model of sepsis induced by cecum ligature and puncture (CLP) in wild-type and Vwf(-/-) mice. Sepsis outcome was studied in those mice and in Adamts-13(-/-) mice. Finally, survival was studied in wild-type mice injected hydrodynamically with the human ADAMTS-13 gene. RESULTS: In wild-type mice, CLP-induced sepsis elicited a significant ADAMTS-13 decrease, and a strong negative correlation existed between VWF and ADAMTS-13. In Vwf(-/-) mice, CLP also induced severe sepsis, but ADAMTS-13 was not significantly diminished. Notably, Vwf(-/-) mice lived significantly longer than wild-type mice. In contrast, Adamts-13(-/-) mice and wild-type mice were comparable with regard to thrombocytopenia, VWF concentrations, absence of thrombi, and survival. Hydrodynamic hADAMTS-13 gene transfer with the pLIVE expression vector resulted in high and stable ADAMTS13 activity in CLP mice; however, no impact on survival was observed. CONCLUSIONS: VWF secretion is a major determinant of ADAMTS-13 decrease in the CLP model, and plays an important role in sepsis-induced mortality, but the complete absence of its regulating protease, ADAMTS-13, had no detectable impact in this sepsis model. Furthermore, increasing ADAMTS-13 activity had no impact on survival.
SUMMARY BACKGROUND: During sepsis, von Willebrand factor (VWF) is abundantly secreted; the main mechanism regulating its size involves specific proteolysis by the metalloprotease ADAMTS-13. OBJECTIVES: To determine whether ADAMTS-13 consumption due to its binding to, and/or cleavage, of VWF contributes to its decrease during sepsis and whether abrogating or enhancing ADAMTS-13 activity influences sepsis outcome. METHODS:ADAMTS-13 activity was evaluated in a model of sepsis induced by cecum ligature and puncture (CLP) in wild-type and Vwf(-/-) mice. Sepsis outcome was studied in those mice and in Adamts-13(-/-) mice. Finally, survival was studied in wild-type mice injected hydrodynamically with the humanADAMTS-13 gene. RESULTS: In wild-type mice, CLP-induced sepsis elicited a significant ADAMTS-13 decrease, and a strong negative correlation existed between VWF and ADAMTS-13. In Vwf(-/-) mice, CLP also induced severe sepsis, but ADAMTS-13 was not significantly diminished. Notably, Vwf(-/-) mice lived significantly longer than wild-type mice. In contrast, Adamts-13(-/-) mice and wild-type mice were comparable with regard to thrombocytopenia, VWF concentrations, absence of thrombi, and survival. Hydrodynamic hADAMTS-13 gene transfer with the pLIVE expression vector resulted in high and stable ADAMTS13 activity in CLPmice; however, no impact on survival was observed. CONCLUSIONS:VWF secretion is a major determinant of ADAMTS-13 decrease in the CLP model, and plays an important role in sepsis-induced mortality, but the complete absence of its regulating protease, ADAMTS-13, had no detectable impact in this sepsis model. Furthermore, increasing ADAMTS-13 activity had no impact on survival.
Authors: Astrid Alflen; Steve Prüfer; Katharina Ebner; Sebastian Reuter; Pamela Aranda Lopez; Inge Scharrer; Fumiaki Banno; Michael Stassen; Hansjörg Schild; Kerstin Jurk; Markus Bosmann; Hendrik Beckert; Markus P Radsak Journal: Sci Rep Date: 2017-08-03 Impact factor: 4.379
Authors: Adam Corken; Susan Russell; Judith Dent; Steven R Post; Jerry Ware Journal: Arterioscler Thromb Vasc Biol Date: 2014-02-06 Impact factor: 8.311
Authors: Hong Yin; Aleksandra Stojanovic-Terpo; Weidong Xu; Adam Corken; Alexander Zakharov; Feng Qian; Sasha Pavlovic; Aleksandar Krbanjevic; Alexander V Lyubimov; Zaijie J Wang; Jerry Ware; Xiaoping Du Journal: Arterioscler Thromb Vasc Biol Date: 2013-09-19 Impact factor: 8.311
Authors: Michael L Ekaney; Clemens L Bockmeyer; Maik Sossdorf; Philipp A Reuken; Florian Conradi; Tobias Schuerholz; Markus F Blaess; Scott L Friedman; Wolfgang Lösche; Michael Bauer; Ralf A Claus Journal: Mol Med Date: 2015-04-03 Impact factor: 6.354
Authors: J A Diaz; T A Fuchs; T O Jackson; J A Kremer Hovinga; B Lämmle; P K Henke; D D Myers; D D Wagner; T W Wakefield Journal: J Vasc Surg Venous Lymphat Disord Date: 2013-10-01
Authors: Michael Schwameis; Christian Schörgenhofer; Alice Assinger; Margarete M Steiner; Bernd Jilma Journal: Thromb Haemost Date: 2014-12-11 Impact factor: 5.249